Unicycive Therapeutics UNCY
NASDAQ UNCY
$3.78 +0.12 (+3.28%)
At close: Nov 11, 2026 · 4:00 PM EST

Unicycive Therapeutics (UNCY) Asset Utilization Ratio (2023 - 2024)

Updated

Unicycive Therapeutics' Asset Utilization Ratio was 0.04 in Q4 2023, up 25.8% from the prior quarter.

Analysis

Unicycive Therapeutics (UNCY) Asset Utilization Ratio (2023 - 2024) Analysis & Trends

For FY2023, Asset Utilization Ratio at Unicycive Therapeutics came in at 0.08, down 10.0% from FY2022.

  • In earlier years, Asset Utilization Ratio was 0.09 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 0.60
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 0.50
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 0.47
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 0.51
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 0.50
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 0.41
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 0.62
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 0.31
10 Unicycive Therapeutics 101.95 Mn -98.02 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 0.02
Dec 31, 2023 0.04
Sep 30, 2023 0.03
Jun 30, 2023 0.06
API Access

Unicycive Therapeutics Asset Utilization Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=UNCY&period=max&api_key=YOUR_API_KEY